What Is a Schedule I Drug? Criteria, Examples, and Penalties

A Schedule I drug is a substance the federal government places in the most restrictive tier of the Controlled Substances Act of 1970, reserved for drugs it considers to have a high potential for abuse, no currently accepted medical use, and no accepted safety even under a doctor’s supervision.¹ No physician can legally prescribe a Schedule I substance, and possessing or distributing one triggers the harshest penalties in federal drug law. The same framework covers heroin, LSD, psilocybin, MDMA, peyote, and marijuana, so substances with very different risk profiles sit under a single legal label.

The Three Criteria That Put a Drug on Schedule I

Federal law places a substance on Schedule I only when it meets all three of the following:¹

A high potential for abuse.
No currently accepted medical use in treatment in the United States.
A lack of accepted safety for use under medical supervision.

The middle criterion is where nearly all of the public argument sits. A drug can fail the “accepted medical use” test even when early studies show promise, because the standard asks whether the FDA and the broader medical community have formally recognized the substance as safe and effective for treating a condition. That creates a loop: Schedule I status makes the research needed to establish medical use much harder to run, and without that research, the classification is unlikely to change.

Common Schedule I Substances

The DEA’s Schedule I list runs into the hundreds and includes many synthetic compounds that never enter public conversation. The substances that come up most often in criminal cases and policy debate include:²

Heroin, a synthetic opioid derived from morphine.
LSD, a hallucinogen classified as Schedule I since 1970.
Psilocybin and psilocyn, the active compounds in psychedelic mushrooms.
MDMA (ecstasy). In 2024, an FDA advisory committee declined to recommend MDMA-assisted therapy for PTSD, leaving the Schedule I status in place.
Peyote, a cactus containing mescaline. Federal law carves out an exemption for certain religious use by the Native American Church.
Methaqualone (Quaalude), a sedative once widely used recreationally.
Marijuana.

Marijuana’s Contested Status

Marijuana is the most disputed name on the list. As of early 2026, it is still Schedule I under federal law even though most states allow it for medical use and a growing number permit recreational use.² The mismatch has real consequences. Someone acting lawfully under state law can still be prosecuted federally, denied federal benefits, or blocked from buying a firearm.

Reclassification has been moving, slowly. In August 2023, the Department of Health and Human Services recommended moving marijuana to Schedule III, citing more than 30,000 healthcare practitioners across 43 U.S. jurisdictions authorized to recommend medical marijuana for over six million patients. The Department of Justice issued a proposed rule in May 2024. A required administrative hearing was postponed in January 2025, and the rulemaking stalled. On December 18, 2025, President Trump signed an executive order directing the Attorney General to complete the rescheduling as quickly as federal law allows.³ The final rule has not been published as of early 2026.

How Schedule I Compares to the Other Schedules

Federal drug schedules run from I to V, with restrictions loosening as the number goes up. The line between Schedule I and everything below it is medical use. Schedule II drugs also carry a high potential for abuse, but they have recognized medical applications, which is why a physician can prescribe pharmaceutical fentanyl or oxycodone for pain but cannot legally prescribe heroin, even though all three are opioids.² Cocaine and methamphetamine are also Schedule II.

Schedule III includes testosterone and ketamine. Schedule IV covers benzodiazepines like Xanax and sleep aids like Ambien. Schedule V contains preparations with limited amounts of narcotics, such as some prescription cough syrups. Penalties and regulatory burdens ease at each step down.

The Federal Analogue Act

Schedule I treatment is not limited to substances named on the list. Under the Federal Analogue Act, a chemical that is structurally similar to a Schedule I or II substance, or that produces similar stimulant, depressant, or hallucinogenic effects, can be prosecuted as though it were Schedule I, provided it was intended for human consumption.⁴ This is how the government pursues designer drugs engineered to slip past existing schedules.

The statute defines an analogue as a substance whose chemical structure is substantially similar to a controlled substance in Schedule I or II, or whose effect on the central nervous system is substantially similar to, or greater than, such a substance.⁵ Manufacturers sometimes market synthetic compounds as “bath salts” or “incense,” with “not for human consumption” labels. That labeling alone is not enough to defeat prosecution; courts look at marketing, pricing, and distribution.⁴

Federal Penalties for Schedule I Offenses

Federal Schedule I penalties split into two tracks. Simple possession carries relatively contained sentences. Manufacturing and distribution move onto a tiered system driven by quantity, and the numbers get large quickly.

Simple Possession

A first-time simple possession conviction can bring up to one year in prison and a minimum $1,000 fine. A second conviction raises the range to 15 days to two years with a minimum $2,500 fine. A third or later conviction means 90 days to three years and a minimum $5,000 fine.⁶ Prior state drug convictions count toward these escalations, not only prior federal ones.

Manufacturing and Distribution

At the baseline, distributing any amount of a Schedule I substance without hitting a specific quantity threshold carries up to 20 years in prison and a fine of up to $1 million for an individual. If death or serious bodily injury results from use of the substance, the sentence jumps to a mandatory 20 years to life.⁷

Larger quantities trigger mandatory minimums that a judge cannot go below. The mid-level tier is 5 to 40 years in prison and fines up to $5 million. Threshold quantities vary by drug: examples include 100 grams of a heroin mixture, 1 gram of an LSD mixture, or 100 marijuana plants.⁷

The top tier imposes 10 years to life and fines up to $10 million, triggered at quantities such as 1 kilogram of a heroin mixture, 10 grams of an LSD mixture, or 1,000 marijuana plants. A prior serious drug felony or violent felony pushes the mandatory minimum to 15 years and the fine ceiling to $20 million. If death results and the defendant has a prior serious conviction, the sentence is mandatory life imprisonment.⁷

Distribution within 1,000 feet of a school, playground, public housing facility, or public pool doubles the maximum punishment and supervised release term for a first offense, with at least one year of imprisonment required. A second offense in a protected zone can triple the penalties, with a three-year minimum sentence.⁸

Asset Forfeiture

Federal law also lets the government seize property tied to Schedule I offenses. Forfeitable assets include vehicles used to transport drugs, cash and financial instruments exchanged for controlled substances, manufacturing equipment, and real estate used to facilitate a drug crime punishable by more than one year in prison. Firearms connected to a drug offense can also be forfeited. The substances themselves, along with manufacturing equipment, are treated as contraband and can be seized summarily.⁹

Consequences Beyond the Criminal Sentence

A Schedule I offense, and in some cases just Schedule I use, can carry consequences that outlast the criminal case.

Federal law bars anyone who is an unlawful user of, or addicted to, a controlled substance from possessing, shipping, or receiving a firearm or ammunition. Conviction is not required; current use is enough to trigger the prohibition. It is also illegal for a seller to transfer a firearm to someone the seller knows or has reason to believe is an unlawful drug user.¹⁰

Public housing agencies must deny admission to applicants currently using illegal drugs. Eviction from federally assisted housing for drug-related activity triggers a mandatory three-year ban on readmission. Agencies also have discretion to deny admission based on past drug activity within a reasonable period before the application, and they can terminate assistance based on a preponderance of evidence that a household member is engaged in drug-related crime, without an arrest or conviction.¹¹

Commercial motor vehicle operators face required drug testing. A positive result for any of five substance classes, marijuana included, brings immediate removal from duty. Returning to work requires an evaluation and treatment program with a substance abuse professional, a passing return-to-duty test, and a minimum of six unannounced follow-up tests over the next 12 months, with follow-up testing extendable for up to five years.¹²

How a Substance Can Be Moved Off Schedule I

Rescheduling follows a formal administrative path. Anyone can petition the Attorney General to start a scheduling change, and the Attorney General or the Secretary of Health and Human Services can also initiate it.¹³ Once a petition is accepted, the Attorney General asks HHS for a scientific and medical evaluation, which HHS runs through the FDA. The review weighs eight factors:

The substance’s actual or relative potential for abuse.
Scientific evidence of its pharmacological effects.
The current state of scientific knowledge about the substance.
Its history and current pattern of abuse.
The scope, duration, and significance of that abuse.
The risk to public health.
Its potential to cause psychological or physical dependence.
Whether it is an immediate precursor of an already-controlled substance.

After HHS finishes, the findings go to the DEA, which decides whether to propose a change. Any proposed change must go through formal rulemaking, including Federal Register publication and public comment. The marijuana effort shows how slow this can move: the HHS recommendation came in August 2023, the proposed rule in May 2024, and by early 2026 the administrative hearing still had not occurred.³

1
Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
2
U.S. Drug Enforcement Administration. Drug Scheduling
3
The White House. Increasing Medical Marijuana and Cannabidiol Research
4
Office of the Law Revision Counsel. 21 USC 813 – Treatment of Controlled Substance Analogues
5
Office of the Law Revision Counsel. 21 USC 802 – Definitions
6
Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession
7
Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
8
Office of the Law Revision Counsel. 21 USC 860 – Distribution or Manufacturing in or Near Schools and Colleges
9
Office of the Law Revision Counsel. 21 USC 881 – Forfeitures
10
Office of the Law Revision Counsel. 18 USC 922 – Unlawful Acts
11
eCFR. 24 CFR 982.553 – Denial of Admission and Termination of Assistance for Criminals and Alcohol Abusers
12
Federal Motor Carrier Safety Administration. Federal Drug and Alcohol Testing Regulations
13
Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances